ALCHEMIST - A151216: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) A screening trial for A081105 and E4512

About this Study

The purpose of this research study is to examine lung cancer patients' surgically removed tumors for certain genetic changes, and to possibly refer these patients to a treatment study with drugs that may specifically target tumors that have these genetic changes. 

Sponsor Protocol ID:A151216
IRB Number:2015-0219
Actively Enrolling
Interventional
Early Phase 1
July 30, 2019
Eligibility Criteria
18 years old
100 years old
Both Male and Female
Yes
No
Yes

Inclusion CriteriaThis study will be available to all eligible patients, regardless of race, gender, or ethnic origin.  

Categories Click category to view its trials.
Cancer
Lungs/Breathing
Participating Locations
Cancer Center and Research Institute
University Hospital
Contact Information
Contact Name: Bridgett Sessions
Phone Number: 601-984-1962
Email: brellis@umc.edu
Principal Investigator:Ruckdeschel, John C, M.D.
How to participate in our Clinical Trials